Volume Spike Investor

Sinovac Biotech Ltd. (AMEX: SVA) is soaring on its report that the Beijing Public Health Bureau has selected Sinovac as ONE OF THE FOUR manufacturers to supply Anflu®, Sinovac’s seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. As of 8:45 AM EST we have seen some 770,000 shares trade hands versus an average volume of about 1.2 million shares. We also see a gain of over 17% at $6.89 in the early indications. BE advised that the 52-week high on this one is (or was) $6.62. -JON OGG